Arbutus Biopharma Corporation ABUS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's software and technology licenses, net?
- Arbutus Biopharma Corporation (ABUS) reported software and technology licenses, net of $131K in Q1 2026.
- How has Arbutus Biopharma Corporation's software and technology licenses, net changed year-over-year?
- Arbutus Biopharma Corporation's software and technology licenses, net increased by 285.3% year-over-year, from $34K to $131K.
- What is the long-term trend for Arbutus Biopharma Corporation's software and technology licenses, net?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's software and technology licenses, net has grown at a 24.2% compound annual growth rate (CAGR), from $44K to $130K.